Joan T Merrill Selected Research

Joan T Merrill Research Topics

Disease

95	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024 - 07/2002
21	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2020 - 03/2003
18	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2004
11	Lupus Nephritis 01/2023 - 11/2005
10	Infections 07/2023 - 10/2012
10	Thrombosis (Thrombus) 01/2021 - 03/2003
7	Inflammation (Inflammations) 01/2021 - 01/2010
6	Atherosclerosis 03/2010 - 09/2002
5	Rheumatoid Arthritis 01/2018 - 04/2006
4	Human Influenza (Influenza) 04/2024 - 08/2011
4	Exanthema (Rash) 01/2023 - 10/2011
4	Neoplasms (Cancer) 12/2021 - 06/2003
4	Nephritis 06/2017 - 04/2009
3	Arthritis (Polyarthritis) 01/2022 - 01/2018
3	Hypertension (High Blood Pressure) 01/2019 - 09/2015
3	Proteinuria 01/2018 - 02/2014
3	Herpes Zoster 01/2017 - 02/2014
3	Venous Thrombosis (Deep-Vein Thrombosis) 12/2005 - 01/2004
2	Acne Vulgaris 01/2023 - 09/2004
2	Headache (Headaches) 12/2021 - 11/2013
2	COVID-19 01/2021 - 10/2020
2	Pre-Eclampsia (Preeclampsia) 01/2019 - 10/2003
2	Stroke (Strokes) 10/2018 - 06/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2017 - 05/2009
2	Neurologic Manifestations (Neurological Manifestations) 01/2016 - 04/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2015 - 01/2013
2	Thrombotic Thrombocytopenic Purpura 01/2015 - 04/2008
2	malar rash 01/2015 - 10/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2005 - 06/2003
1	Ataxia (Dyssynergia) 04/2024
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 04/2024
1	Chronic Disease (Chronic Diseases) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Fatigue 01/2023
1	Neutropenia 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Skin Neoplasms (Skin Cancer) 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Rheumatic Diseases (Rheumatism) 01/2021

Drug/Important Bio-Agent (IBA)

21	AutoantibodiesIBA 04/2024 - 06/2003
13	AntibodiesIBA 04/2024 - 10/2003
11	InterferonsIBA 01/2022 - 11/2011
10	Antiphospholipid AntibodiesIBA 01/2023 - 01/2004
10	belimumabIBA 11/2022 - 01/2008
10	Monoclonal AntibodiesIBA 11/2022 - 12/2002
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2008
8	B-Cell Activating FactorIBA 12/2023 - 01/2008
8	Antinuclear AntibodiesIBA 01/2022 - 04/2006
7	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2003
7	Estrogens (Estrogen)FDA Link 01/2018 - 06/2005
6	Immunoglobulin G (IgG)IBA 01/2021 - 03/2003
6	Interferon Type IIBA 01/2018 - 01/2010
5	GlucocorticoidsIBA 12/2023 - 02/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2009
5	anifrolumabIBA 01/2022 - 01/2017
5	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 06/2005
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 10/2003
4	LigandsIBA 12/2023 - 06/2003
4	Prednisone (Sone)FDA LinkGeneric 12/2023 - 07/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2002
4	Complement System Proteins (Complement)IBA 10/2020 - 01/2013
4	SteroidsIBA 01/2018 - 07/2002
4	Dehydroepiandrosterone (DHEA)IBA 11/2005 - 07/2002
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 12/2021
3	TACI receptor-IgG Fc fragment fusion proteinIBA 11/2021 - 08/2008
3	CytokinesIBA 12/2014 - 01/2013
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
3	CholesterolIBA 03/2010 - 09/2002
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 04/2008 - 06/2003
3	Anticardiolipin AntibodiesIBA 12/2005 - 03/2003
2	AntigensIBA 04/2024 - 10/2016
2	VaccinesIBA 04/2024 - 01/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2023 - 01/2022
2	iberdomideIBA 04/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2014
2	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 11/2005
2	Antirheumatic Agents (DMARD)IBA 01/2018 - 11/2014
2	AMG623 peptibodyIBA 01/2018 - 08/2015
2	tocilizumab (atlizumab)FDA Link 01/2018 - 11/2014
2	CreatinineIBA 06/2017 - 02/2014
2	sifalimumabIBA 11/2016 - 11/2011
2	Prostaglandins AIBA 01/2016 - 08/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013 - 04/2008
2	Endothelial Protein C ReceptorIBA 03/2012 - 05/2009
2	Interleukin-2 (IL2)IBA 09/2011 - 06/2011
2	Rituximab (Mabthera)FDA Link 01/2010 - 10/2003
2	Protein SIBA 01/2010 - 10/2003
2	CD11b AntigenIBA 03/2009 - 02/2008
2	LipidsIBA 06/2003 - 09/2002
1	KinesinsIBA 04/2024
1	telitaciceptIBA 12/2023
1	Antigen Receptors (Antigen Receptor)IBA 07/2023
1	deucravacitinibIBA 01/2023
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2023
1	Platelet Factor 4IBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	FibrinIBA 01/2021

Therapy/Procedure

17	Therapeutics 05/2024 - 09/2004
1	Drug Tapering 12/2023